Found 266 matching trials
A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC
PHASE2This is a prospective, multi-center, single arm study assessing the efficac...
Location
Henan Cancer Hospital
Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases
PHASE2This is a single arm, multicenter phase II trial for 60 patients with untre...
Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer
PHASE2Small Cell Lung cancer (SCLC) is a highly aggressive tumor that accounts fo...
Location
Sixth People's Hospital of Luoyang
AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer
PHASE3This is a phase 3 study. All subjects are patients with unresectable locall...
Status
Active Not Recruiting
Location
Harbin Medical University Cancer Hospital
A Phase II Study of Adjuvant Durvalumab Combined With GEMOX/GC Chemotherapy Followed by Lenvatinib Versus Capecitabine in Biliary Tract Cancer.
PHASE2This study is designed as a prospective, randomized, open-label, phase II c...
Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH), Beijing, 100730
Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC
PHASE1The combination of chemotherapy with PD-1 immune checkpoint blockade agents...
Status
Active Not Recruiting
Location
Institut Jules Bordet
Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab
PHASE4Lung cancer presents a significant treatment challenge, particularly in the...
Location
Amsterdam UMC, location VU Medical center
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC
N/AMulti-center observational clinical study to evaluate the application value...
Location
Parc de Salut Mar - Hospital del Mar
Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC
PHASE2This is a Phase II, open label, randomized study of durvalumab in combinati...
Location
Huntsman Cancer Institute at University of Utah
Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer
PHASE1This is a randomized, open, comparative, multi-centre study which will recr...
Location
Institut Ste Catherine